Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine
- 21 August 2000
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 745 (2) , 373-388
- https://doi.org/10.1016/s0378-4347(00)00300-5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimensJournal of Antimicrobial Chemotherapy, 1998
- High-performance liquid chromatographic determination of GS4071, a potent inhibitor of influenza neuraminidase, in plasma by precolumn fluorescence derivatization with naphthalenedialdehydeJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza InfectionAntimicrobial Agents and Chemotherapy, 1998
- Biexponential decomposition of a neuraminidase inhibitor prodrug (GS-4104) in aqueous solution.Pharmaceutical Research, 1998
- Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza ActivityJournal of the American Chemical Society, 1997